Literature DB >> 7844656

Injection drug users in the Midwest: an epidemiologic comparison of drug use patterns in four Ohio cities.

H A Siegal1, R G Carlson, J Wang, R S Falck, R C Stephens, E D Nelson.   

Abstract

Variations in the drug use patterns of injection drug users (IDUs) can have important implications for public health efforts aimed at reducing drug abuse and the transmission of the human immunodeficiency virus. This article describes and compares the characteristics of IDUs living in four Ohio cities and compares African-American and White IDUs at a statewide level. Data from 2,001 IDUs who were recruited for the National AIDS Demonstration Research project between 1989 and 1991 in Columbus, Cleveland, Cincinnati, and Dayton were compared on a number of variables by city and by ethnicity using descriptive statistics and ANCOVA analysis. Significant differences among IDUs in the four cities exist for the use of alcohol, marijuana, cocaine, crack, heroin, speedball, other opioids, shooting gallery use, "safer" needle practices, treatment history, and self-help participation. Differences by ethnicity emerged on all variables except marijuana use, overall injection frequency, and incarceration experience. The results suggest that dramatic differences exist between African-American and White IDUs, and among IDUs in cities relatively close together, regardless of ethnicity. These findings should be considered when developing policy and programs for prevention and treatment activities targeting IDUs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7844656     DOI: 10.1080/02791072.1994.10472440

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  9 in total

Review 1.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

Review 2.  Challenges in understanding disparities in drug use and its consequences.

Authors:  Sandro Galea; Sasha Rudenstine
Journal:  J Urban Health       Date:  2005-06       Impact factor: 3.671

Review 3.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

4.  National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.

Authors:  Susan Calcaterra; Jason Glanz; Ingrid A Binswanger
Journal:  Drug Alcohol Depend       Date:  2013-01-05       Impact factor: 4.492

5.  Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.

Authors:  Raminta Daniulaityte; Ramzi W Nahhas; Sydney Silverstein; Silvia Martins; Angela Zaragoza; Avery Moeller; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2019-09-22       Impact factor: 4.492

6.  Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.

Authors:  Ajay Manhapra; Lantie Quinones; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2016-01-13       Impact factor: 4.492

7.  Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine.

Authors:  Kyungbo Kim; Jianzhuang Yao; Zhenyu Jin; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2018-08-04       Impact factor: 5.192

8.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10

9.  Assessing and improving needle exchange programs: gaps and problems in the literature.

Authors:  Kate Ksobiech
Journal:  Harm Reduct J       Date:  2004-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.